Provision of first contact physiotherapy in primary care across the UK: a survey of the service.


Journal

Physiotherapy
ISSN: 1873-1465
Titre abrégé: Physiotherapy
Pays: England
ID NLM: 0401223

Informations de publication

Date de publication:
09 2020
Historique:
received: 16 08 2019
pubmed: 22 7 2020
medline: 25 2 2021
entrez: 22 7 2020
Statut: ppublish

Résumé

First Contact Physiotherapy (FCP) is an emerging model of care whereby a specialist physiotherapist located within general practice undertakes the first patient assessment, diagnosis and management without a prior GP consultation. Despite institutional and professional body support for this model and NHS commitment to its implementation, data regarding current FCP provision are limited. To identify current FCP service provision across the UK, including models of provision and key professional capabilities. Cross-sectional online survey, targeting physiotherapists and service managers involved in FCP. Recruitment involved non-probability sampling targeting those involved in FCP service provision through emails to members of known clinical networks, snowballing and social media. The survey gathered data about respondents, FCP services and the role and scope of physiotherapists providing FCP. The authors received 102 responses; 32 from service managers and 70 working in FCP practice from England (n=60), Scotland (n=22), Wales (n=14), and Northern Ireland (n=2). Most practitioners were NHS band 7 or 8a (91%, n=63), with additional skills (e.g. requesting investigations, prescribing). 17% (12/70) worked 37.5hours/week; 37% (26/70) ≤10hours; most (71%, 50/70) used 20-minute appointments (range 10-30minutes); varying arrangements were reported for administration and follow-up. Services covered populations of 1200 to 600,000 (75% <100,000); access mostly involved combinations of self-booking and reception triage. Commissioning and funding arrangements varied widely; NHS sources provided 90% of services. This survey provides new evidence regarding variation in FCP practice across the UK, indicating that evidence-informed, context specific guidance on optimal models of provision is required.

Sections du résumé

BACKGROUND
First Contact Physiotherapy (FCP) is an emerging model of care whereby a specialist physiotherapist located within general practice undertakes the first patient assessment, diagnosis and management without a prior GP consultation. Despite institutional and professional body support for this model and NHS commitment to its implementation, data regarding current FCP provision are limited.
OBJECTIVES
To identify current FCP service provision across the UK, including models of provision and key professional capabilities.
DESIGN
Cross-sectional online survey, targeting physiotherapists and service managers involved in FCP.
METHODS
Recruitment involved non-probability sampling targeting those involved in FCP service provision through emails to members of known clinical networks, snowballing and social media. The survey gathered data about respondents, FCP services and the role and scope of physiotherapists providing FCP.
RESULTS
The authors received 102 responses; 32 from service managers and 70 working in FCP practice from England (n=60), Scotland (n=22), Wales (n=14), and Northern Ireland (n=2). Most practitioners were NHS band 7 or 8a (91%, n=63), with additional skills (e.g. requesting investigations, prescribing). 17% (12/70) worked 37.5hours/week; 37% (26/70) ≤10hours; most (71%, 50/70) used 20-minute appointments (range 10-30minutes); varying arrangements were reported for administration and follow-up. Services covered populations of 1200 to 600,000 (75% <100,000); access mostly involved combinations of self-booking and reception triage. Commissioning and funding arrangements varied widely; NHS sources provided 90% of services.
CONCLUSIONS
This survey provides new evidence regarding variation in FCP practice across the UK, indicating that evidence-informed, context specific guidance on optimal models of provision is required.

Identifiants

pubmed: 32693238
pii: S0031-9406(20)30339-4
doi: 10.1016/j.physio.2020.04.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2-9

Subventions

Organisme : Department of Health
ID : 16/116/03
Pays : United Kingdom

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Auteurs

Serena Halls (S)

Faculty of Health and Applied Sciences, University of the West of England, Glenside Campus, Blackberry Hill, Stapleton BS16 1DD, Bristol, UK. Electronic address: Serena.Halls@uwe.ac.uk.

Rachel Thomas (R)

Faculty of Health and Applied Sciences, University of the West of England, Glenside Campus, Blackberry Hill, Stapleton BS16 1DD, Bristol, UK. Electronic address: Rachel4.Thomas@uwe.ac.uk.

Hannah Stott (H)

Faculty of Health and Applied Sciences, University of the West of England, Glenside Campus, Blackberry Hill, Stapleton BS16 1DD, Bristol, UK. Electronic address: Hannah3.Stott@uwe.ac.uk.

Margaret E Cupples (ME)

Centre for Public Health Research, Queen's University, Belfast, Institute of Clinical Science, Royal Victoria Hospital, Grosvenor Road, Belfast BT12 6BA, UK. Electronic address: m.cupples@qub.ac.uk.

Paula Kersten (P)

School of Health Sciences, University of Brighton, Brighton BN1 9PH, UK. Electronic address: P.Kersten@brighton.ac.uk.

Fiona Cramp (F)

Faculty of Health and Applied Sciences, University of the West of England, Glenside Campus, Blackberry Hill, Stapleton BS16 1DD, Bristol, UK. Electronic address: Fiona.Cramp@uwe.ac.uk.

Dave Foster (D)

Faculty of Health and Applied Sciences, University of the West of England, Glenside Campus, Blackberry Hill, Stapleton BS16 1DD, Bristol, UK. Electronic address: Dave.Foster@rocketmail.com.

Nicola Walsh (N)

Faculty of Health and Applied Sciences, University of the West of England, Glenside Campus, Blackberry Hill, Stapleton BS16 1DD, Bristol, UK. Electronic address: Nicola.Walsh@uwe.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH